Hagenbrunn, Austria

Norman Brunner

This inventor holds 1 USPTO granted patent. Top assignee: Chemisch Pharmazeutische Forschungsgesellschaft M.b.h.. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Norman Brunner

Introduction

Norman Brunner is a notable inventor based in Hagenbrunn, Austria. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to the creation of innovative solutions that have potential applications in various industries.

Latest Patents

One of Norman Brunner's key patents is titled "Sulphamoylthiophenes, a process for their preparation." This patent focuses on the synthesis of sulphamoylathiophenes, which are compounds characterized by the formula ##STR1##, where Y can denote either oxygen (O) or sulfur (S). This invention showcases his expertise in chemical processes and highlights his ability to contribute to advancements in pharmaceutical research. He holds 1 patent.

Career Highlights

Throughout his career, Norman Brunner has been associated with Chemisch Pharmazeutische Forschungsgesellschaft M.b.h., a company dedicated to pharmaceutical research and development. His role in this organization has allowed him to explore innovative chemical processes and contribute to the advancement of drug development.

Collaborations

Norman Brunner has collaborated with several talented individuals in his field, including Dieter Binder and Franz Rovenszky. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

Norman Brunner's contributions to the field of chemistry and his innovative patent on sulphamoylthiophenes demonstrate his commitment to advancing pharmaceutical research. His work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…